Background & Aims Cardiovascular disease remains the leading cause of death in patients
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …

Based on the assumption that characterizing the history of a disease will help in improving
practice while offering a clue to research, this article aims at reviewing the history of …

Background & Aims Fibrosis affects prognoses for patients with nonalcoholic fatty liver
disease (NAFLD). Several non-invasive scoring systems have aimed to identify patients at …

Background There are increasing data on the association between non‐alcoholic fatty liver
disease (NAFLD) and cardiovascular diseases (CVD). Aim To summarise evidence on the …

Objective Numerous studies have assessed the association between Nonalcoholic fatty liver
disease (NAFLD) and cardiovascular disease (CVD). However, results have been conflicting …

Methods Embase and Medline were searched for articles relating to NAFLD, carotid
atherosclerosis, and stroke. Proportional data was analysed using a generalized linear …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is strongly increasing and may
put patients at increased risk for atherosclerotic cardiovascular disease (asCVD). Both …

Background Metabolically healthy obesity (MHO) shows a reduced risk compared with
obese patients with adverse metabolic conditions. Lean people suffering some metabolic …

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of
atherosclerotic cardiovascular disease. In our meta‐analysis, we aimed to assess the …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) could play a catalytic role in
the development of metabolic comorbidities, although the magnitude of this effect in …